Spirit Halloween presented a check to Covenant Children’s on Thursday morning as part of their annual Spirit of Children ...
Katy Beckermann, MD, PhD, explained that oncology nurses and APPs should be ready to administer and explain dose modifications for patients with RCC.
Researchers project a hospital bed shortage in less than a decade due to health care staffing shortages across the U.S., ...
Aptose Biosciences (NASDAQ:APTO;TSX:APS), a clinical-stage oncology stock, reports dose-escalation approval for tuspetinib, ...
Out-of-pocket costs like deductibles and copays deter people with cancer from complying with treatment.This creates a ...
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Among 19 neuroblastoma patients treated with CAR T-cell therapy, eight survived more than 5 years after infusion, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback